Pfizer reportedly strikes $5.4 billion deal for Global Blood Therapeutics
Pfizer Inc. PFE, -1.18% has reached an agreement to buy Global Blood Therapeutics Inc. [s :gbt] in a deal valued at $5.4 billion, the Wall Street Journal reported, citing people familiar with the matter. The news comes after the Journal reported Friday that the two were in advanced talks. Pfizer will pay $68.
50- a share in cash for Global Blood Therapeutics, which has one of few approved treatments for sickle-cell disease. The companies are expected to announce the deal later Monday. Global Blood Therapeutics shares rose 1.8% in premarket trade Monday, and are up 118% in the year to date, while the S&P 500 SPX, -0.16% has fallen 13%.
France Dernières Nouvelles, France Actualités
Similar News:Vous pouvez également lire des articles d'actualité similaires à celui-ci que nous avons collectés auprès d'autres sources d'information.
Pfizer in talks on $5 billion acquisition: mediaAmerican drugmaker Pfizer is close to a deal to purchase Global Blood Therapeutics, which manufactures a recently approved drug against sickle-cell anemia, for $5 billion, the Wall Street Journal has reported.
Lire la suite »
Satellite Data May Have Underestimated Global Warming, Scientists SayAccording to a new study, our satellite data may have underestimated the warming of the troposphere over the last four decades.
Lire la suite »
‘Top Gun: Maverick’ Flies Past $1.35 Billion at the Global Box Office'Maverick' has surpassed 'Black Panther' and takes aim at 'Avengers: Age of Ultron's spot on the list of highest-grossing films of all time.
Lire la suite »
‘Elvis’ Dances Past $250 Million at the Global Box OfficeThe critically acclaimed 'Elvis' continues to make its mark as it crosses $250 million at the global box office.
Lire la suite »
Beyond Meat Plans to Lay Off 4% of Global WorkforceBeyond Meat is cutting 4% of its global workforce The layoffs are part of its plan to reduce costs as inflation prompts consumers to buy less-expensive protein.
Lire la suite »
China's exports gain steam but outlook cloudy as global growth coolsOutbound shipments have been one of the few bright spots for the Chinese economy in 2022, as widespread lockdowns hit businesses and consumers hard.
Lire la suite »